IHH Healthcare Berhad (KLSE:IHH)
Malaysia · Delayed Price · Currency is MYR 8.69
-0.09 (-1.03%)
At close: Jun 15, 2026
IHH Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 26,004 | 25,745 | 24,383 | 20,935 | 17,989 | 17,132 |
Other Revenue | - | - | - | - | - | 86.06 |
| 26,004 | 25,745 | 24,383 | 20,935 | 17,989 | 17,218 | |
Revenue Growth (YoY) | 5.19% | 5.59% | 16.47% | 16.38% | 4.48% | 28.45% |
Cost of Revenue | 17,369 | 17,208 | 16,061 | 13,870 | 11,817 | 11,219 |
Gross Profit | 8,635 | 8,537 | 8,322 | 7,065 | 6,172 | 5,999 |
Selling, General & Admin | 151 | 144 | 123 | 113 | 87.96 | 80.65 |
Amortization of Goodwill & Intangibles | 65 | 53 | 53 | 48 | 49.51 | 47.25 |
Other Operating Expenses | 2,583 | 2,587 | 2,572 | 1,192 | 1,862 | 1,394 |
Operating Expenses | 4,761 | 4,721 | 4,492 | 2,915 | 3,394 | 2,870 |
Operating Income | 3,874 | 3,816 | 3,830 | 4,150 | 2,777 | 3,128 |
Interest Expense | -1,015 | -1,009 | -787 | -688 | -471.66 | -444.56 |
Interest & Investment Income | 180 | 177 | 107 | 87 | 77.59 | 49.08 |
Earnings From Equity Investments | 33 | 32 | 29 | 26 | 38.87 | 39.86 |
Currency Exchange Gain (Loss) | -11 | -9 | 142 | -194 | -144.19 | -604.97 |
Other Non Operating Income (Expenses) | -46 | -59 | -260 | 658 | 455.77 | 455.48 |
EBT Excluding Unusual Items | 3,015 | 2,948 | 3,061 | 4,039 | 2,734 | 2,623 |
Merger & Restructuring Charges | -5 | -5 | - | - | - | -1.27 |
Impairment of Goodwill | - | - | - | - | -150.07 | - |
Gain (Loss) on Sale of Investments | 14 | 14 | 6 | 2 | 0.99 | 0.93 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 14.98 |
Asset Writedown | 86 | 69 | 200 | 8 | -367.56 | -82.19 |
Other Unusual Items | 528 | 402 | 489 | - | - | - |
Pretax Income | 3,638 | 3,428 | 3,756 | 4,049 | 2,217 | 2,556 |
Income Tax Expense | 981 | 821 | 594 | 658 | 571.95 | 379.15 |
Earnings From Continuing Operations | 2,657 | 2,607 | 3,162 | 3,391 | 1,645 | 2,177 |
Minority Interest in Earnings | -542 | -506 | -505 | -439 | -96.74 | -314.06 |
Net Income | 2,115 | 2,101 | 2,657 | 2,952 | 1,548 | 1,863 |
Preferred Dividends & Other Adjustments | - | - | - | - | 52.21 | 88.3 |
Net Income to Common | 2,115 | 2,101 | 2,657 | 2,952 | 1,496 | 1,774 |
Net Income Growth | -11.98% | -20.93% | -9.99% | 90.65% | -16.87% | 544.74% |
Shares Outstanding (Basic) | 8,833 | 8,828 | 8,808 | 8,807 | 8,803 | 8,782 |
Shares Outstanding (Diluted) | 8,834 | 8,830 | 8,811 | 8,807 | 8,804 | 8,783 |
Shares Change (YoY) | 0.22% | 0.22% | 0.04% | 0.03% | 0.25% | 0.04% |
EPS (Basic) | 0.24 | 0.24 | 0.30 | 0.34 | 0.17 | 0.20 |
EPS (Diluted) | 0.24 | 0.24 | 0.30 | 0.34 | 0.17 | 0.20 |
EPS Growth | -12.21% | -21.12% | -10.02% | 97.28% | -15.89% | 790.65% |
Free Cash Flow | 2,176 | 2,128 | 1,156 | 1,888 | 1,999 | 2,504 |
Free Cash Flow Per Share | 0.25 | 0.24 | 0.13 | 0.21 | 0.23 | 0.28 |
Dividend Per Share | 0.105 | 0.105 | 0.100 | 0.090 | 0.070 | 0.060 |
Dividend Growth | 5.00% | 5.00% | 11.11% | 28.57% | 16.67% | 50.00% |
Gross Margin | 33.21% | 33.16% | 34.13% | 33.75% | 34.31% | 34.84% |
Operating Margin | 14.90% | 14.82% | 15.71% | 19.82% | 15.44% | 18.17% |
Profit Margin | 8.13% | 8.16% | 10.90% | 14.10% | 8.32% | 10.30% |
Free Cash Flow Margin | 8.37% | 8.27% | 4.74% | 9.02% | 11.11% | 14.55% |
EBITDA | 5,350 | 5,255 | 5,123 | 5,270 | 3,817 | 4,124 |
EBITDA Margin | 20.57% | 20.41% | 21.01% | 25.17% | 21.22% | 23.95% |
D&A For EBITDA | 1,476 | 1,439 | 1,293 | 1,120 | 1,040 | 995.92 |
EBIT | 3,874 | 3,816 | 3,830 | 4,150 | 2,777 | 3,128 |
EBIT Margin | 14.90% | 14.82% | 15.71% | 19.82% | 15.44% | 18.17% |
Effective Tax Rate | 26.96% | 23.95% | 15.82% | 16.25% | 25.80% | 14.84% |